Insulet Corporation

BOVESPA:P2OD34 Stock Report

Market Cap: R$117.7b

Insulet Past Earnings Performance

Past criteria checks 5/6

Insulet has been growing earnings at an average annual rate of 74.2%, while the Medical Equipment industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 20.2% per year. Insulet's return on equity is 37.6%, and it has net margins of 21.2%.

Key information

74.2%

Earnings growth rate

73.0%

EPS growth rate

Medical Equipment Industry Growth12.3%
Revenue growth rate20.2%
Return on equity37.6%
Net Margin21.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Insulet makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BOVESPA:P2OD34 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,984421842201
30 Jun 241,873395788204
31 Mar 241,781234745205
31 Dec 231,697206708205
30 Sep 231,557120694213
30 Jun 231,46563653200
31 Mar 231,3681622187
31 Dec 221,3055588180
30 Sep 221,24317538173
30 Jun 221,17835515165
31 Mar 221,14245484163
31 Dec 211,09917466160
30 Sep 211,037-29474157
30 Jun 21996-30446158
31 Mar 219599411152
31 Dec 209047384147
30 Sep 2086829334144
30 Jun 2082618320137
31 Mar 207775315135
31 Dec 1973812298132
30 Sep 1969417270126
30 Jun 1965317268117
31 Mar 1960014251103
31 Dec 18564324895
30 Sep 18529-1324980
30 Jun 18500-1722778
31 Mar 18486-2321877
31 Dec 17464-2720976
30 Sep 17437-2919172
30 Jun 17410-3017965
31 Mar 17387-2616860
31 Dec 16367-2716656
30 Sep 16347-3415953
30 Jun 16324-4915649
31 Mar 16297-6214948
31 Dec 15264-6213943
30 Sep 15253-5112938
30 Jun 15256-4412635
31 Mar 15268-5612829
31 Dec 14231-4810828
30 Sep 14285-4911227
30 Jun 14271-5911526
31 Mar 14259-4010824
31 Dec 13247-4511722

Quality Earnings: P2OD34 has high quality earnings.

Growing Profit Margin: P2OD34's current net profit margins (21.2%) are higher than last year (7.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: P2OD34's earnings have grown significantly by 74.2% per year over the past 5 years.

Accelerating Growth: P2OD34's earnings growth over the past year (250.8%) exceeds its 5-year average (74.2% per year).

Earnings vs Industry: P2OD34 earnings growth over the past year (250.8%) exceeded the Medical Equipment industry 1.9%.


Return on Equity

High ROE: Whilst P2OD34's Return on Equity (37.65%) is high, this metric is skewed due to their high level of debt.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 18:36
End of Day Share Price 2024/12/16 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Insulet Corporation is covered by 58 analysts. 22 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anand VankawalaAvondale Partners
Jeffrey JohnsonBaird
null nullBaird